Human Psychopharmacology-Clinical and Experimental

Papers
(The TQCC of Human Psychopharmacology-Clinical and Experimental is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
28
26
The prevalence of constipation in adult psychiatric out‐patients on clozapine treatment at a regional public hospital in Hong Kong26
Effect of fasedienol (PH94B) pherine nasal spray and steroidal hormones on electrogram responses and autonomic nervous system activity in healthy adult volunteers18
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression18
A diffusion tensor imaging study in schizophrenia patients with clozapine induced obsessive compulsive symptoms18
Co‐ingestion of prescription drugs and alcohol in US adults aged 50 years or older17
A Naturalistic Examination of the Acute Effects of High‐Potency Cannabis on Emotion Regulation Among Young Adults: A Pilot Study16
Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms16
15
Factors influencing concentrations of risperidone and 9‐hydroxyrisperidone in psychiatric outpatients taking immediate‐release formulations of risperidone13
Restless Legs Syndrome among patients receiving antipsychotic and antidepressant drugs12
Prospective analysis of serum prolactin levels, clinical symptomatology and sexual functions in patients with schizophrenia switched to paliperidone palmitate 3‐monthly from paliperidone palmitate 1‐m10
Issue Information10
Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological st9
Effects of the active botanical blend “WKUP GT” on attention and cognitive functions after lunch in healthy volunteers9
Characteristics of antipsychotic drug‐induced hypothermia in psychogeriatric inpatients9
Issue Information8
8
Issue Information8
Reply to: 5‐MeO‐DMT has not been found in traditional ayahuasca preparations and the combination of 5‐MeO‐DMT with MAOIs is dangerous7
Effects of COVID‐19 Lockdowns on Alcohol Consumption, Hangovers and Smoking Among Young Adults (n = 140) in Germany: An On‐Line Study7
Efficacy and safety of hydroxyzine for sleep in adults: Systematic review6
Stress, caffeine and psychosis‐like experiences—A double‐blind, placebo‐controlled experiment6
Renal effects of long‐term lithium therapy, revisited6
Issue Information5
5
Corrigendum5
The antimuscarinic agent biperiden selectively impairs recognition of abstract figures without affecting the processing of non‐words5
Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma‐aminobutyric acid–benzodiazepine receptor agonists or suvorexant5
Issue Information5
Hypothalamic‐pituitary‐adrenal and autonomic response to psychological stress in abstinent alcohol use disorder individuals with and without depressive symptomatology5
Nick Drake: A Troubled Mind, a Troublesome ‘Cure’4
The impact of adjunctive aripiprazole on QT interval: A 12‐week open label study in patients on olanzapine, clozapine or risperidone4
Issue Information4
Nx4 attenuated stress‐induced activity of the anterior cingulate cortex—A post‐hoc analysis of a randomized placebo‐controlled crossover trial4
Analysis of schizophrenia‐associated genetic markers in the HLA region as risk factors for tardive dyskinesia4
Dexamphetamine increased speech and visual unimodal illusions in healthy participants without affecting temporal binding window4
Safety and efficacy of Withania somnifera for anxiety and insomnia: Systematic review and meta‐analysis3
3
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans3
Efficacy and acceptability of adjunctive n‐acetylcysteine for psychotic disorders: Systematic review and meta‐analysis3
Alcohol Consumption During the COVID‐19 Pandemic: A Critical Review3
Issue Information3
3
Facilitated extinction of conditioned fear responses by delta 9‐tetrahyrdrocannabidol in humans: a pilot study3
Treatment of depression: Are psychotropic drugs appropriately dosed in women and in the elderly? Dosages of psychotropic drugs by sex and age in routine clinical practice3
Corrigendum3
0.41510987281799